Clinical Trials Directory

Trials / Sponsors / Impax Laboratories, LLC

Impax Laboratories, LLC

Industry · 20 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Parkinson Disease
Phase 42025-02-12
CompletedA TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects
Cardiac Repolarization in Healthy Subjects
Phase 12023-10-30
CompletedOpen Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Part
Parkinson Disease
Phase 32019-04-03
CompletedA Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuati
Parkinson's Disease (Disorder)
Phase 32018-11-06
CompletedEfficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Migraine
Phase 32017-11-27
CompletedA Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease
Advanced Parkinson's Disease
Phase 22016-11-14
CompletedA Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease
Parkinson's Disease
Phase 22015-11-01
CompletedSafety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
Restless Legs Syndrome
Phase 22011-11-01
CompletedCarbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Saf
Parkinson's Disease
Phase 32011-08-01
CompletedA Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IP
Parkinson's Disease
Phase 32010-05-01
CompletedAn Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Diseas
Parkinson's Disease
Phase 32010-03-01
CompletedA Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
Parkinson's Disease
Phase 32009-09-01
CompletedA Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Spasticity, Multiple Sclerosis
Phase 22009-04-01
CompletedA Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Parkinson's Disease
Phase 32009-04-01
CompletedA Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa
Parkinson's Disease
Phase 22008-11-01
CompletedIPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Multiple Sclerosis
Phase 32007-06-01
CompletedComparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease
Idiopathic Parkinson's Disease
Phase 22006-01-01
CompletedComparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease
Parkinson's Disease
Phase 22005-11-01
CompletedPharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease
Idiopathic Parkinson's Disease
Phase 1 / Phase 22005-10-01
CompletedEfficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents
Migraine
Phase 32003-09-01